Books > Medicine > General issues > Public health & preventive medicine
|
Buy Now
Selling Sickness (Paperback)
Loot Price: R472
Discovery Miles 4 720
You Save: R62
(12%)
|
|
Selling Sickness (Paperback)
(sign in to rate)
List price R534
Loot Price R472
Discovery Miles 4 720
You Save R62 (12%)
Expected to ship within 10 - 15 working days
|
Donate to Against Period Poverty
Total price: R492
Discovery Miles: 4 920
|
Thirty years ago, Henry Gadsden, the head of Merck, one of the
world's largest drug companies, told Fortune magazine that he
wanted Merck to be more like chewing gum maker Wrigley's. It had
long been his dream to make drugs for healthy people so that Merck
could "sell to everyone." Gadsden's dream now drives the marketing
machinery of the most profitable industry on earth. Drug companies
are systematically working to widen the very boundaries that define
illness, and the markets for medication grow ever larger. Mild
problems are redefined as serious illness and common complaints are
labeled as medical conditions requiring drug treatments. Runny
noses are now allergic rhinitis, PMS has become a psychiatric
disorder, and hyperactive children have ADD. When it comes to
conditions like high cholesterol or low bone density, being "at
risk" is sold as a disease. Selling Sickness reveals how widening
the boundaries of illness and lowering the threshold for treatments
is creating millions of new patients and billions in new profits,
in turn threatening to bankrupt health-care systems all over the
world. As more and more of ordinary life becomes medicalized, the
industry moves ever closer to Gadsden's dream: "selling to
everyone."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.